Actively Recruiting
Are Elastic Restraints Still Necessary in Improved Rehabilitation Programs After Hip and Knee Prosthetic Surgery?
Led by Clinique Pasteur Lanroze · Updated on 2026-04-06
1274
Participants Needed
1
Research Sites
138 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Venous thrombosis and pulmonary embolism are considered serious and potentially preventable complications of hip and knee replacement surgery. The risks of thrombosis must be weighed against the risks associated with preventive measures, both mechanical and pharmacological. Modern medicine is now questioning the use of elastic restraints in surgery. Several studies have investigated the benefits of using restraints to prevent thromboembolic events. These studies have shown no additional benefit from the use of compression stockings in thromboembolism prevention. To the best of our knowledge, no orthopedic study has investigated the non-inferiority of pharmacological treatment compared with elastic compression devices, specifically in knee and hip surgery. The aim of this multicenter, prospective, randomized study is to investigate whether pharmacological prophylaxis alone is non-inferior to pharmacological and mechanical prophylaxis (using restraints) of peripheral venous thrombosis or pulmonary embolism up to 90 days after prosthetic surgery.
CONDITIONS
Official Title
Are Elastic Restraints Still Necessary in Improved Rehabilitation Programs After Hip and Knee Prosthetic Surgery?
Who Can Participate
Eligibility Criteria
You may qualify if you...
- First line and non-traumatic total hip or knee arthroplasty
- Patient included in an Enhanced Rehabilitation after Surgery (ERS) or "fast-track" protocol, or scheduled as an outpatient.
You will not qualify if you...
- Patient requiring long-term anticoagulation for pre-existing co-morbidity
- Patients with coagulation disorders (hypercoagulability)
- Patient undergoing thrombogenic pharmacological treatment
- History of obliterative arteriopathy of the lower limbs
- Arterial disease
- Obesity
- Heart failure
- Chronic bronchopneumopathy
- Lymphedema
- Chronic inflammatory disease
- Permanent wearing of elastic restraints
- Proximal or distal arterial bypass surgery
- Creatinine clearance < 15 ml/min
- Inability to give consent
- Revision surgery for hip or knee prosthesis
- Metastatic cancer
- Life expectancy less than 3 months
- Allergy to socks or compression stockings
- Patients presenting one or more exclusion criteria for the fast-track protocol (severe or poorly-balanced associated conditions such as diabetes or immunodepression, inability to contact the doctor or hospital department if necessary, pre-operative ASA score greater than or equal to 4)
- Adults under guardianship or curatorship
- Vulnerable persons in accordance with article L1121-6 of the CSP (French Public Health Code)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Clinique Pasteur Lanroze
Brest, France, 29000
Actively Recruiting
Research Team
R
Romain Gérard, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here